Bristol-Myers Squibb EuroCharity's RSS for Bristol-Myers Squibb en 2010 28th Monday of May 2018 08:05:37 AM 28th Monday of May 2018 08:05:37 AM en 2010 Logo U.S. Food and Drug Administration accepts Bristol-Myers Squibb’s Application for Opdivo In combination with Yervoy for the treatment of adults with microsatellite instability high 2018-03-27 13:04:26 13092 2010-03-23T15:57:28Z Bristol Myers Squibb named one of the 2018 "Top 70 Companies for Executive Women" By the National Association for Female Executives 2018-03-06 16:03:47 13089 2010-03-23T15:57:28Z Bristol Myers Squibb announces expansion of the International Immuno-Oncology Network The II-ON brings industry and academia together with the goal of advancing Immuno-Oncology research 2018-02-26 16:03:38 13090 2010-03-23T15:57:28Z Collaboration between Bristol-Myers Squibb and Nektar Therapeutics For Nektar’s lead immuno-oncology program, NKTR-214 2018-02-14 16:03:56 13091 2010-03-23T15:57:28Z Bristol-Myers Squibb Announces Topline Results from CheckMate - 214 A Phase 3 Study of Opdivo in Combination with Yervoy in Intermediate and Poor-Risk Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma 2017-08-18 11:03:15 13101 2010-03-23T15:57:28Z